Cozad Asset Management Inc. boosted its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 25.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 32,282 shares of the health services provider's stock after buying an additional 6,630 shares during the quarter. Cozad Asset Management Inc.'s holdings in Universal Health Services were worth $6,066,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in UHS. Norges Bank bought a new stake in Universal Health Services during the fourth quarter valued at approximately $67,964,000. Invesco Ltd. grew its holdings in shares of Universal Health Services by 25.6% in the fourth quarter. Invesco Ltd. now owns 1,241,340 shares of the health services provider's stock worth $222,721,000 after purchasing an additional 253,385 shares during the last quarter. Freestone Grove Partners LP bought a new position in shares of Universal Health Services in the fourth quarter worth about $41,155,000. AQR Capital Management LLC grew its holdings in Universal Health Services by 59.4% during the 4th quarter. AQR Capital Management LLC now owns 590,389 shares of the health services provider's stock worth $105,928,000 after acquiring an additional 219,942 shares in the last quarter. Finally, Bridgewater Associates LP boosted its holdings in shares of Universal Health Services by 119.1% in the 4th quarter. Bridgewater Associates LP now owns 322,163 shares of the health services provider's stock valued at $57,802,000 after buying an additional 175,131 shares in the last quarter. 86.05% of the stock is currently owned by institutional investors.
Universal Health Services Price Performance
Shares of UHS stock traded down $2.77 during mid-day trading on Friday, reaching $163.69. The stock had a trading volume of 610,347 shares, compared to its average volume of 853,969. Universal Health Services, Inc. has a 12-month low of $152.33 and a 12-month high of $243.25. The company has a market cap of $10.64 billion, a P/E ratio of 8.63, a price-to-earnings-growth ratio of 0.68 and a beta of 1.28. The business has a 50-day simple moving average of $177.42 and a 200 day simple moving average of $180.01. The company has a current ratio of 1.29, a quick ratio of 1.23 and a debt-to-equity ratio of 0.64.
Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The health services provider reported $5.35 earnings per share for the quarter, beating analysts' consensus estimates of $4.85 by $0.50. The business had revenue of $4.28 billion during the quarter, compared to analysts' expectations of $4.24 billion. Universal Health Services had a return on equity of 18.22% and a net margin of 7.66%. The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $4.31 earnings per share. On average, sell-side analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.
Universal Health Services Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Tuesday, September 2nd will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 2nd. Universal Health Services's dividend payout ratio (DPR) is presently 4.21%.
Insider Transactions at Universal Health Services
In other Universal Health Services news, Director Maria Ruderman Singer sold 1,097 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $191.48, for a total value of $210,053.56. Following the sale, the director directly owned 7,884 shares of the company's stock, valued at approximately $1,509,628.32. This trade represents a 12.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 16.40% of the company's stock.
Analyst Ratings Changes
A number of research firms have issued reports on UHS. Stephens raised shares of Universal Health Services to a "hold" rating in a research report on Monday, June 2nd. Baird R W cut shares of Universal Health Services from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays lifted their price target on Universal Health Services from $257.00 to $259.00 and gave the stock an "overweight" rating in a report on Wednesday. Bank of America lowered Universal Health Services from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $215.00 to $185.00 in a report on Wednesday, July 16th. Finally, Guggenheim initiated coverage on shares of Universal Health Services in a research report on Wednesday, April 9th. They issued a "buy" rating and a $208.00 target price on the stock. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $218.92.
Get Our Latest Stock Analysis on UHS
Universal Health Services Profile
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.